These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 22213804)

  • 41. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection.
    Lauer GM; Barnes E; Lucas M; Timm J; Ouchi K; Kim AY; Day CL; Robbins GK; Casson DR; Reiser M; Dusheiko G; Allen TM; Chung RT; Walker BD; Klenerman P
    Gastroenterology; 2004 Sep; 127(3):924-36. PubMed ID: 15362047
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection.
    Keoshkerian E; Hunter M; Cameron B; Nguyen N; Sugden P; Bull R; Zekry A; Maher L; Seddiki N; Zaunders J; Kelleher A; Lloyd AR;
    J Viral Hepat; 2016 Dec; 23(12):985-993. PubMed ID: 27558465
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determinants of viral clearance and persistence during acute hepatitis C virus infection.
    Thimme R; Oldach D; Chang KM; Steiger C; Ray SC; Chisari FV
    J Exp Med; 2001 Nov; 194(10):1395-406. PubMed ID: 11714747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro activation and differentiation of naïve CD4+ and CD8+ T cells into HCV core- and NS3-specific armed effector cells: a new role for CD4+ T cells.
    Krishnadas DK; Li W; Kumar R; Tyrrell LJ; Agrawal B
    Cell Immunol; 2009; 259(2):141-9. PubMed ID: 19616202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient-derived hepatitis C virus inhibits CD4⁺ but not CD8⁺ T lymphocyte proliferation in primary T cells.
    MacParland SA; Chen AY; Corkum CP; Pham TN; Michalak TI
    Virol J; 2015 Jun; 12():93. PubMed ID: 26084511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: implications for vaccine design.
    Smyk-Pearson S; Tester IA; Lezotte D; Sasaki AW; Lewinsohn DM; Rosen HR
    J Infect Dis; 2006 Aug; 194(4):454-63. PubMed ID: 16845628
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non-genotype 1 infection.
    Schulze Zur Wiesch J; Lauer GM; Timm J; Kuntzen T; Neukamm M; Berical A; Jones AM; Nolan BE; Longworth SA; Kasprowicz V; McMahon C; Wurcel A; Lohse AW; Lewis-Ximenez LL; Chung RT; Kim AY; Allen TM; Walker BD
    Blood; 2007 Sep; 110(5):1559-69. PubMed ID: 17475911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort.
    Post JJ; Pan Y; Freeman AJ; Harvey CE; White PA; Palladinetti P; Haber PS; Marinos G; Levy MH; Kaldor JM; Dolan KA; Ffrench RA; Lloyd AR; Rawlinson WD;
    J Infect Dis; 2004 May; 189(10):1846-55. PubMed ID: 15122521
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses.
    Ulsenheimer A; Lucas M; Seth NP; Tilman Gerlach J; Gruener NH; Loughry A; Pape GR; Wucherpfennig KW; Diepolder HM; Klenerman P
    J Viral Hepat; 2006 Oct; 13(10):708-14. PubMed ID: 16970603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection.
    Semmo N; Krashias G; Willberg C; Klenerman P
    J Viral Hepat; 2007 Jul; 14(7):492-502. PubMed ID: 17576391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers.
    Day CL; Seth NP; Lucas M; Appel H; Gauthier L; Lauer GM; Robbins GK; Szczepiorkowski ZM; Casson DR; Chung RT; Bell S; Harcourt G; Walker BD; Klenerman P; Wucherpfennig KW
    J Clin Invest; 2003 Sep; 112(6):831-42. PubMed ID: 12975468
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comprehensive longitudinal analysis of hepatitis C virus (HCV)-specific T cell responses during acute HCV infection in the presence of existing HIV-1 infection.
    van den Berg CH; Ruys TA; Nanlohy NM; Geerlings SE; van der Meer JT; Mulder JW; Lange JA; van Baarle D
    J Viral Hepat; 2009 Apr; 16(4):239-48. PubMed ID: 19222746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sustained virological response after early antiviral treatment of acute hepatitis C virus and HIV coinfection.
    Schulze Zur Wiesch J; Pieper D; Stahmer I; Eiermann T; Buggisch P; Lohse A; Hauber J; van Lunzen J
    Clin Infect Dis; 2009 Aug; 49(3):466-72. PubMed ID: 19580412
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages.
    Rosen HR; Miner C; Sasaki AW; Lewinsohn DM; Conrad AJ; Bakke A; Bouwer HG; Hinrichs DJ
    Hepatology; 2002 Jan; 35(1):190-8. PubMed ID: 11786976
    [TBL] [Abstract][Full Text] [Related]  

  • 55. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
    Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C.
    Penna A; Missale G; Lamonaca V; Pilli M; Mori C; Zanelli P; Cavalli A; Elia G; Ferrari C
    Hepatology; 2002 May; 35(5):1225-36. PubMed ID: 11981773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immune responses during acute and chronic infection with hepatitis C virus.
    Ishii S; Koziel MJ
    Clin Immunol; 2008 Aug; 128(2):133-47. PubMed ID: 18514579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection.
    Kim AY; Schulze zur Wiesch J; Kuntzen T; Timm J; Kaufmann DE; Duncan JE; Jones AM; Wurcel AG; Davis BT; Gandhi RT; Robbins GK; Allen TM; Chung RT; Lauer GM; Walker BD
    PLoS Med; 2006 Dec; 3(12):e492. PubMed ID: 17194190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection.
    Bain C; Parroche P; Lavergne JP; Duverger B; Vieux C; Dubois V; Komurian-Pradel F; Trépo C; Gebuhrer L; Paranhos-Baccala G; Penin F; Inchauspé G
    J Virol; 2004 Oct; 78(19):10460-9. PubMed ID: 15367612
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunopathogenesis of hepatitis C virus infection.
    Chang KM
    Clin Liver Dis; 2003 Feb; 7(1):89-105. PubMed ID: 12691460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.